Synthesis of bombesin analogues for radiolabeling with rhenium-188

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2354-2359

  Safavy, Ahmad ^a   Khazaeli, M B ^b   Qin, Haoyu ^a   Buchsbaum, Donald J ^a  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Bombesin analogues; Cancer imaging; Cancer therapy; Rhenium labeling; Trisuccin

Indexed keywords

BOMBESIN DERIVATIVE; RHENIUM 188;

ANIMAL CELL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CELL STRAIN 3T3; CONFERENCE PAPER; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DENSITY;

EID: 0031458825     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2354::aid-cncr4>3.0.co;2-b     Document Type: Conference Paper

References (23)

1. Fischman AJ, Babich JW, Strauss HW. A ticket to ride: peptide radiopharmaceuticals. J Nucl Med 1993;34:2253-63.
2. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetrachloro-3α, 6α-diphenylglycoluril. Biochem Biophys Res Commun 1978;80:849-57.
3. Garg S, Garg PK, Zalutsky MR. Acylation reagents for the radiohalogenation of peptides. J Labelled Comp Radiopharm 1993;32:212-3.
4. Babich JW, Solomon H, Pike MC, Kroon D, Graham W, Abrams MJ, et al. Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection. J Nucl Med 1993;34:1964-74.
5. Baidoo KE, Stathis M, Scheffel V, Lever SZ, Wagner HN. High affinity Tc-labeled chemotactic peptides. J Nucl Med 1993;34:18P.
6. 111In labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide. Bioconjug Chem 1995;6:683-90.
7. Fischman AJ, Pike MC, Kroon D, Fucello AJ, Rexinger D, ten Kate C, et al. Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med 1991;32:483-91.
8. Smith-Jones P, Stolz B, Albert R, Reist H, Burns C, Macke H. A gallium labeled desferrioxamine/somatostatin analog (SDZ 216927). J Labelled Comp Radiopharm 1993;32:422-3.
9. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 1994;331:1116-21.
10. Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Lipszyc H, Lee H, et al. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 1996;37:1016-22.
11. Varnum JM, Thakur ML, Schally AV, Jansen S, Mayo KH. Rhenium-labeled somatostatin analog RC-160. 1H NMR and computer modeling conformational analysis. J Biol Chem 1994;269:12583-8.
12. Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B, et al. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 1995;36:1-6.
13. Lee JD, Kim DI, Lee JT, Chang JW, Park CY. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI. J Nucl Med 1995; 36:537-41.
14. 90Y. J Labelled Comp Radiopharm 1995;37:519-21.
15. Smith-Jones PM, Stolz B, Albert R, Ruser G, Macke H, Briner U, et al. Synthesis, radiolabelling, and evaluation of DTPA/ octreotide conjugates for radiotherapy. J Labelled Comp Radiopharm 1995;37:499-501.
16. Moody TW, Pert CB, Gazdar AF, Carney DN, Minna JD. High levels of intracellular bombesin characterize human small-cell lung carcinoma. Science 1981;214:1246-8.
17. Coy DH, Taylor JE, Jiang NY, Kim SH, Wang LH, Huang SC, et al. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and Swiss 3T3 cells display strong antimitotic activity. J Biol Chem 1989;264:14691-7.
18. Hoffman TJ, Sieckman GL, Volkert WA. Targeting small cell lung cancer using iodinated peptide analogs. J Labelled Comp Radiopharm 1995;37:321-3.
19. Safavy A, Buchsbaum DJ, Khazaeli MB. Synthesis of N-[tris-[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]-succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents. Bioconjug Chem 1993;4:194-8.
20. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid phase synthesis of peptides. Anal Biochem 1970;34:595-8.
21. 2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector mediated gene transfer. J Nucl Med. 1997;38:1221-9.
22. Safavy A, Sanders A, Qin H, Buchsbaum DJ. Conjugation of N-[Tris[2-(N-hydroxyamino)carbonyl]ethyl]methyl] succinamic acid, to monoclonal antibody CC49 by an improved active ester protocol. Bioconjugate Chem 1997;8:766-71.
23. Bodanszky M. Principles of peptide synthesis. 2nd edition. Berlin: Springer-Verlag, 1993:29-38.